Finally, we identified SLC17A7 as a bivalent tumor suppressor gene in GBM by demonstrating its down-regulation at both the protein and RNA levels in GBM tissues compared with normal brain tissues. This evidence concerns the gene SLC17A7 and glioblastoma.